Levonorgestrel Intrauterine System (LNG IUS) in Menorrahgia: A Follow-Up Study

Gupta Taru,Jain Jyoti,Bhatia Pushpa,Gupta Nupur,Gupta Sangeeta,Kumar Sushma

doi:10.4236/ojog.2014.44032

Abstract

Objective: To study the acceptability, efficacy, adverse effect and user satisfaction of Levonorgestrel intrauterine system (LNG IUS) for treatment of menorrahgia. Method: This was an observational descriptive study conducted in ESI PGIMSR over a period from Jan 2008-June 2011. 70 women presented in O.P.D with heavy menstrual bleeding having no contraindication for device, consenting for LNG IUS underwent its insertion. Menstrual pattern, pictorial blood loss assessment chart score, adverse effects, and rate of acceptability and satisfaction were recorded at 3, 6 and 12 months after procedure. Results: The mean age of the sample was 39.92 yrs ± 3.27. Indication for device insertion was DUB in 81.42% (57), fibroid 8.57% (6), adenomyosis in 10% (7). The expulsion rate was 4.2% (3), removal rate was 7.14% (5) and continuation rate is 88.57% (62). 2.28% (3) patients underwent hysterectomy because of continuous bleeding even after 3 - 4 months of insertion. On follow-up at one year out of 62 patients, 33.87% (21) were amenorrhic and 51.61% (32) have regular period, while 3.07% (2) patients had irregular period. Conclusion: LNG IUS is a less invasive, effective treatment modality for menorrahgia with reasonable efficacy.

Highlights

Menorrahgia constitutes a considerable problem for many female, causing discomfort, anxiety and decreased quality of life
The prevalence of menorrhagia typically ranges from 9% to 14% in studies that assessed menstrual blood loss objectively with acid haematin or from 20% to 52% in studies based on subjective assessment with pictorial blood loss assessment chart (PBAC) [6]
Patients are insured beneficiaries and Levonorgestrel Intrauterine System (LNG IUS) was provided free of cost to them

Summary

Introduction

Menorrahgia constitutes a considerable problem for many female, causing discomfort, anxiety and decreased quality of life. Menorrahgia is experienced by up to 30% of women in their child bearing age and accounts for 60%. How to cite this paper: Taru, G., Nupur, G., Sangeeta, G., Pushpa, B., Jyoti, J. and Sushma, K. (2014) Levonorgestrel Intrauterine System (LNG IUS) in Menorrahgia: A Follow-Up Study. Open Journal of Obstetrics and Gynecology, 4, 190-196. It is a common cause of iron deficiency anaemia in healthy fertile female [1] [2]. Menorrahgia denotes regularly timed episodes of bleeding that are excessive in amount (>80 ml and/ duration of flow > 5 days) [3]-[5]. The prevalence of menorrhagia typically ranges from 9% to 14% in studies that assessed menstrual blood loss objectively with acid haematin or from 20% to 52% in studies based on subjective assessment with pictorial blood loss assessment chart (PBAC) [6]

Methods

Results

Conclusion